117
Views
7
CrossRef citations to date
0
Altmetric
Original Research

Study on the Formation of Antihypertensive Twin Drugs by Caffeic Acid and Ferulic Acid with Telmisartan

, , , ORCID Icon &
Pages 977-992 | Published online: 05 Mar 2020

References

  • GongX, TangXJ, HanZP, XiaBH. Evaluation of blood pressure smoothing index in comparison between lacidipine and telmisartan. Guide Chin Med. 2011;9:253–254.
  • LiuY, SuY, TangJG. Telmisartan combined with amlodipine were used to improve the blood pressure variability in patients with type 2 diabetes and essential hypertension. J Third Mil Med Univ. 2013;35:275–276.
  • ParatiG, SchumacherH. Blood pressure variability over 24h: prognostic implications and treatment perspectives. An assessment using the smoothness index with telmisartan-amlodipine monotherapy and combination. Hypertens Res. 2014;37:187–193. doi:10.1038/hr.2013.14524305518
  • ParatiG, DolanE, LeyL, SchumacherH. Impact of antihypertensive combination and monotreatments on blood pressure variability: assessment by old and new indices. Data from a large ambulatory blood pressure monitoring database. J Hypertens. 2014;32:1326–1333. doi:10.1097/HJH.000000000000016924759124
  • YuQ, YaoFY, DaiHX. Research on progress of blood pressure variability and target organ damage of essential hypertension. Chin J Evid Based Cardiovasc Med. 2018;10:508–510.
  • MezueK, GoyalA, PressmanGS, MatthewR, HorrowJC, RangaswamiJ. Blood pressure variability predicts adverse events and cardiovascular outcomes in SPRINT. J Clin Hypertens(Greenwich). 2018;9:1–6.
  • ZhangHX, FanQX, XueSZ, ZhangM, ZhaoJX. Twenty-four-hour blood pressure variability plays a detrimental role in the neurological outcome of hemorrhagic stroke. J Int Med Res. 2018;46:2558–2568. doi:10.1177/030006051876046329865917
  • WilsonJL, WarburtonR, TaylorL, ToksozD, HillN, PolgarP. Unraveling endothelin-1 induced hypercontractility of human pulmonary artery smooth muscle cells from patients with pulmonary arterial hypertension. PLoS One. 2018;13:1–19. doi:10.1371/journal.pone.0195780
  • ParkBG, ShinWS, OhS, ParkGM, KimNI, LeeS. A novel antihypertension agent, sargachromenol D from marine brown algae, sargassum siliquastrum, exerts dual action as an L-type Ca2+ channel blocker and endothelin A/B2 receptor antagonist. Bioorg Med Chem. 2017;25:4649–4655. doi:10.1016/j.bmc.2017.07.00228720331
  • WangF, LiuM, YangLC, et al. Caffeic acid, ferulic acid: a new kind of non-peptide endothelin antagonist. Chin J Clin Pharmacol Ther. 1999;4:85–92.
  • AliciO, KavakliHS, KocaC, AltintasND, AydinM, AliciS. Value of caffeic acid phenethyl ester pretreatment in experimental sepsis model in rats. Mediators Inflamm. 2015;8:1–6. doi:10.1155/2015/810948
  • WuL, LiX, WangL, TangY, XueM. Proliferative inhibition of danxiongfang and its active ingredients on rat vascular smooth muscle cell and protective effect on the VSMC damage induced by hydrogen peroxide. J Ethnopharmacol. 2009;126:197–206. doi:10.1016/j.jep.2009.08.04519735709
  • KangBY, KleinhenzJM, MurphyTC, HartCM. The PPARγ ligand rosiglitazone attenuates hypoxia-induced endothelin signaling in vitro and in vivo. Am J Physiol Lung Cell Mol Physiol. 2011;301:L881–91. doi:10.1152/ajplung.00195.201121926265
  • HassanzadehP, ArbabiE, AtyabiF, DinarvandR. Ferulic acid-loaded nanostructured lipid carriers: A promising nanoformulation against the ischemic neural injuries. Life Sci. 2018;193:64–76. doi:10.1016/j.lfs.2017.11.04629196052
  • LiJ, BaiY, BaiY, et al. Pharmacokinetics of caffeic acid, ferulic acid, formononetin, cryptotanshinone, and tanshinone IIA after oral administration of Naoxintong capsule in rat by HPLC-MS/MS. Evid Based Complement Alternat Med. 2017;5:1–12.
  • SuMY, ZhouTT, ZhouMJ. Pharmacokinetics of caffeic acid in rats. China Pharm. 2008;19:1220–1222.
  • WangSJ, ZhangZQ, ZhaoYH, RuanJX, LiJL. Simultaneous quantification of chlorogenic acid and caffeic acid in rat plasma after an intravenous administration of mailuoning injection using liquid chromatography/mass spectrometry. Rapid Commun Mass Spectrom. 2006;20:2303–2308. doi:10.1002/(ISSN)1097-023116810636
  • ShiB, YangL, GaoT. Pharmacokinetic profile and metabolite identification of bornyl caffeate and caffeic acid in rats by high performance liquid chromatography coupled with mass spectrometry. RSC Adv. 2019;9:4015–4027. doi:10.1039/C8RA07972B
  • WeifaY, ZhimingZ, HaiboZ, LingshuaiH. Synthesis of telmisartan and its derivatives and evaluation of their biological activities. Chin J Org Chem. 2006;26(3):318–323.
  • LiY-Q, JiH, ZhangY-H, et al. WB1106, a novel nitric oxide-releasing derivative of telmisartan, inhibits hypertension and improves glucose metabolism in rats. Eur J Pharmacol. 2007;577(1–3):100–108. doi:10.1016/j.ejphar.2007.08.00817822696
  • JieZ, SujunW, BenkunY, YunmingZ, LinquanZ, LingliW. Absolute bioavailability of caffeic acid in rats and its intestinal absorption properties. China J Chin Mater Med. 2013;38(23):4152–4156.
  • FumingS, YufengG, hehuiX, et al. Arterial baroreflex function determines the survival time in lipopolysaccharide-induced shock in rats. Shock. 2004;21(6):556–560. doi:10.1097/01.shk.0000126647.51109.5c15167685
  • TaoX, ZhangS-H, ShenF-M, et al. High level apoptosis is persistent in myocardiocytes of sinoaortic-denervated rats. J Hypertens. 2004;22(3):557–563. doi:10.1097/00004872-200403000-0001915076162
  • WangJ, ShenFM, WangMW, SuDF. Effects of nine antihypertensive drugs on blood pressure variability in sinoaortic-denervated rats. Acta Pharmacol Sin. 2006;27(8):1013–1017. doi:10.1111/j.1745-7254.2006.00381.x16867252
  • FuYJ, ShuH, MiaoCY, WangMW, SuDF. Restoration of baroreflex function by ketanserin is not blood pressure dependent in conscious freely moving rats. J Hypertens. 2004;22:1165–1172. doi:10.1097/00004872-200406000-0001815167452
  • WangN, AhmadH, YongmingJ, et al. Identification of polygala oligosaccharide esters and their metabolites in rat plasma after oral administration of ethanol extract of Kai Xin San by UHPLC-MS. Acta Pharm Sin. 2017;52(10):1592–1598.
  • WenbaoL, FanghuaD, ChangjunS. Recent progress in research on prodrugs of nucleoside drugs. Progress Pharm Sci. 2012;36(07):300–307.
  • XiuliL, JingchaoS, ZitaoG, DafangZ, XiaoyanC. Carboxylesterase 2 and intestine transporters contribute to the low bioavailability of allisartan, a prodrug of Exp3174 for hypertension treatment in humans. Drug Metab Dispos. 2019;5:1–22.
  • LiY, WangY, ZhangR, et al. Improving the oral bioavailability of tapentadol via a carbamate prodrug approach: synthesis, bioactivation, and pharmacokinetics. Drug Deliv Transl Res. 2018;8(5):1335–1344. doi:10.1007/s13346-018-0524-629777509